Bispecific anti-CEAXCD3 T cell activating antigen binding molecule Application JP-7044700-B2 Japan 30 Mar 2022
ANTI-CEACAM5 ANTIBODIES AND CONJUGATES AND USES THEREOF Application WO-2022048883-A1 World Intellectual Property Organisation (WIPO) 10 Mar 2022
ANTI-CEACAM5 ANTIBODIES AND USES THEREOF Application EA-039377-B1 Eurasian Patent Organisation 20 Jan 2022
Bispecific T cell activating antigen binding molecules Grant US-11117965-B2 United States of America 14 Sep 2021
Bispecific T cell activating antigen binding molecules Grant US-10781258-B2 United States of America 22 Sep 2020
Bispecific T cell activating antigen binding molecules Grant US-10781257-B2 United States of America 22 Sep 2020
Bispecific T cell activating antigen binding molecules Grant US-10766967-B2 United States of America 08 Sep 2020
Disease therapy by inducing immune response to Trop-2 expressing cells Grant US-10662252-B2 United States of America 26 May 2020
Bispecific T cell activating antigen binding molecules Grant US-10611841-B2 United States of America 07 Apr 2020
Bispecific T cell activating antigen binding molecules Grant US-10611840-B2 United States of America 07 Apr 2020
Methods of treating CEA-positive cancers using PD-1 axis binding antagonists and anti-CEA/a… Grant US-10596257-B2 United States of America 24 Mar 2020
Murine, chimeric, humanized or human anti-TNF-alpha antibodies Grant US-10385139-B2 United States of America 20 Aug 2019
T-cell redirecting bispecific antibodies for treatment of disease Grant US-10308688-B2 United States of America 04 Jun 2019
Combination therapy for inducing immune response to disease Grant US-10245321-B2 United States of America 02 Apr 2019
T-cell redirecting bispecific antibodies for treatment of disease Grant US-10239938-B2 United States of America 26 Mar 2019
T-cell redirecting bispecific antibodies for treatment of disease Grant US-10183992-B2 United States of America 22 Jan 2019
Bispecific T cell activating antigen binding molecules Grant US-10155815-B2 United States of America 18 Dec 2018
Combination therapy for inducing immune response to disease Grant US-10111954-B2 United States of America 30 Oct 2018
Murine, chimeric, humanized or human anti-IL-6 antibodies Grant US-9932413-B2 United States of America 03 Apr 2018
Bispecific T cell activating antigen binding molecules Grant US-9914776-B2 United States of America 13 Mar 2018
Disease therapy by inducing immune response to Trop-2 expressing cells Grant US-9879088-B2 United States of America 30 Jan 2018
Combination therapy for inducing immune response to disease Grant US-9682143-B2 United States of America 20 Jun 2017
Disease therapy by inducing immune response to Trop-2 expressing cells Grant US-9670286-B2 United States of America 06 Jun 2017
BISPECIFIC ANTI-CEAXCD3 T CELL ACTIVATING ANTIGEN BINDING MOLECULES Application WO-2017055389-A1 World Intellectual Property Organisation (WIPO) 06 Apr 2017
Bispecific antibodies that neutralize both TNF-α and IL-6: novel therapeutic agent for… Grant US-9416197-B2 United States of America 16 Aug 2016
Disease therapy by inducing immune response to Trop-2 expressing cells Grant US-9382329-B2 United States of America 05 Jul 2016
T-cell redirecting bispecific antibodies for treatment of disease Grant US-9315567-B2 United States of America 19 Apr 2016